|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.9 SEK | +5.68% |
|
+22.43% | +81.13% |
| Apr. 18 | Diamyd Medical Raises SEK57 Million in Rights Issue | MT |
| Apr. 12 | Recruitment Milestone Reaches in Diamyd® Phase 3 Trial | CI |
Diamyd Medical AB (publ) reported earnings results for the full year ended August 31, 2023. For the full year, the company reported sales was SEK 0.546 million compared to SEK 0.454 million a year ago. Revenue was SEK 19.61 million compared to SEK 2.58 million a year ago.
Net loss was SEK 100.21 million compared to SEK 103.52 million a year ago. Basic loss per share from continuing operations was SEK 1.3 compared to SEK 1.4 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +81.13% | 111M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.73B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
DIAMYD MEDICAL AB 
